drugset / Trial / NCT01306669

Influenza Vaccine Trial in HIV Uninfected Pregnant Women

NCT01306669

RandomizedParallel-groupQuadruple-blindPrevention

Summary

Randomised, double blind, placebo controlled trial to assess safety, immunogenicity and efficacy of Trivalent Influenza vaccine in HIV uninfected pregnant women

Timeline

Start
2011-03-03
Primary completion
2013-05
Completion
2013-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Influenza Virus Vaccine Vaccine 0.5 ml Intramuscular

Indications